Skip to main content
HCPCS J1299 · Level II · Part B drug

J1299: eculizumab (Soliris), HCPCS Level II J code

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: ASP payment limits: October 2026 (effective October 1, 2026); NCCI MUE tables: 2026 Q4 (effective October 1, 2026); NCCI PTP edits: v323r0 (2026 Q4) (effective October 1, 2026); OPPS Addendum B: October 2026 (effective October 1, 2026); ASC Addendum BB (covered ancillary services): October 2026 (effective October 1, 2026). Next CMS release: January 1, 2027 (quarterly update).

Key facts for J1299

Billing unit
2 MG
Inj, eculizumab, 2 mg
ASP payment limit
$43.763
October 2026; -1.0% vs July 2026
Practitioner MUE
600
MAI 3
OPPS status
SI K
APC 2070
NCCI exposure
no PTP pairs
Coverage articles
1
5 states

TL;DR

HCPCS J1299 is the Level II code for Injection, eculizumab, 2 mg, billed per 2 MG. The Medicare Part B ASP payment limit for October 2026 is $43.763 per billing unit, down 1.0% from July 2026. The practitioner MUE allows up to 600 units per date of service (MAI 3), so a full 600-unit day is $26,257.80 at the current limit. Under OPPS it carries status indicator K in APC 2070. J1299 is billed in units of 2 MG; the quantity administered, the NDC package and the units on the claim must reconcile, which is the check that prevents CARC 16 and 151 returns on this line. Other HCPCS codes whose descriptor names eculizumab: Q5151 (biosimilar eculizumab-aagh (Epysqli) from Nupathe Inc); Q5152 (biosimilar eculizumab-aeeb (Bkemv) from Amgen Inc). The ASP crosswalk maps 1 NDC to it, sold as Soliris by Alexion Pharmaceuticals, Inc. 1 Medicare coverage article lists the code across 5 states, including A54548.

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J1299 at $43.763 per 2 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $44.198 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J1299
QuarterPayment limitPerCoinsurance
October 2026$43.7632 MG20%
July 2026$44.1982 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 1 NDC from 1 labeler to J1299. Report the NDC in the claim's drug segment and bill the number of J1299 units that equals the quantity administered divided by 2 MG; the last column gives units per full package.

NDCs that crosswalk to J1299
NDCDrug nameLabelerPackage sizeBilling units / package
25682-0001-01SolirisAlexion Pharmaceuticals, Inc.30 × 1150

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J1299. For practitioners the limit is 600 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J1299 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services6003 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital6003 Date of Service Edit: ClinicalPrescribing Information
DME supplier6003 Date of Service Edit: ClinicalPrescribing Information

MUE for J1299 in every setting opens the lookup with this code filled in, next to any other code on the same claim.

NCCI edits and add-on relationships

No active practitioner PTP pair lists J1299 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

The counts above are exposure, not answers for a specific claim. Check J1299 against another code to see whether a given pair bundles, which code is paid and whether a modifier can separate them.

J1299 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists J1299 in their HCPCS tables, covering 5 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J1299
ArticleTitleContractor(s)StatesRelated LCD
A54548Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI®-eculizumab-aagh, and BKEMV™-eculizumab-aeebWellpoint FederalCT IL MN NY WIL33394

Diagnoses Medicare contractors cover for J1299

One billing and coding article attaches a covered diagnosis list to J1299: 18 distinct ICD-10-CM codes in all. The 15 below come first by how many of those articles cover them, then in the contractor's own order. The claim line is checked against the list of the contractor that processes it, and a diagnosis outside that list is denied as not medically necessary (CARC 50).

First 15 covered ICD-10-CM codes for J1299
ICD-10-CMDescription (FY2027)Articles covering
D59.31Infection-associated hemolytic-uremic syndrome1 of 1
D59.32Hereditary hemolytic-uremic syndrome1 of 1
D59.39Other hemolytic-uremic syndrome1 of 1
D59.5Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]1 of 1
G36.0Neuromyelitis optica [Devic]1 of 1
G70.00Myasthenia gravis without (acute) exacerbation1 of 1
G70.01Myasthenia gravis with (acute) exacerbation1 of 1
N00.6Acute nephritic syndrome with dense deposit disease1 of 1
N00.B1Acute nephritic syndrome with idiopathic immune membranoproliferative glomerulonephritis (IC-MPGN)1 of 1
N00.B2Acute nephritic syndrome with secondary immune complex membranoproliferative glomerulonephritis (IC-MPGN)1 of 1
N01.6Rapidly progressive nephritic syndrome with dense deposit disease1 of 1
N02.6Recurrent and persistent hematuria with dense deposit disease1 of 1
N03.6Chronic nephritic syndrome with dense deposit disease1 of 1
N04.6Nephrotic syndrome with dense deposit disease1 of 1
N04.B1Nephrotic syndrome with idiopathic immune complex membranoproliferative glomerulonephritis (IC-MPGN)1 of 1
3 more codes are in the full lists linked below.

Contractors split an article's diagnoses into numbered groups and say in each group's instructions which procedure codes it supports. Only the groups that apply to J1299 are counted here. The full list opens on the policy page with every group, the non-covered codes and the instructions.

Covered diagnosis lists that apply to J1299, by article
ArticleContractorGroups that applyCovered codes for J1299Full list
A54548Wellpoint Federalone list for every code in the article18On LCD L33394

Local coverage policies that list J1299

1 active Local Coverage Determination lists J1299 in the policy or in its billing and coding article. Each applies only in its contractor's jurisdiction; check the one for the state where the drug is administered.

Hospital outpatient (OPPS) status

In the October 2026 OPPS Addendum B, J1299 carries status indicator K and is assigned to APC 2070, with a published national unadjusted payment of $43.763. Status K means the drug is paid separately under OPPS at the ASP-based rate rather than packaged into the procedure.

Ambulatory surgical center (ASC) payment

In the October 2026 ASC Addendum BB (covered ancillary services), J1299 carries payment indicator K2, which CMS defines as "Drugs, biologicals, and radiopharmaceuticals paid separately when provided integral to a surgical procedure on ASC list; payment based on OPPS rate". The national ASC payment is $43.76 per 2 MG, paid only when the drug is furnished integral to a covered surgical procedure.

Common denials for J1299 and how to prevent them

NDC missing, invalid or not matched to the HCPCS code

units billed exceed the MUE for the date of service

diagnosis not covered by the applicable coverage article or LCD

For teams evaluating QuickIntell software

Evaluate a coding workflow for J1299

Use the unit, NDC and edit questions in this reference to scope a QuickCode evaluation for qualified coder review, documentation clarification and the billing handoff. Confirm supported code sets, data inputs and reviewer responsibilities; the reference tables do not establish that a particular automated check or payer integration is available.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — HCPCS J1299

What does HCPCS code J1299 describe?

J1299 is defined by CMS as "Injection, eculizumab, 2 mg". Each billing unit represents 2 MG, so the units reported on the claim must equal the dose administered divided by that unit.

Is J1299 a CPT code?

No. J1299 is a HCPCS Level II code, the letter-plus-four-digit set CMS maintains for drugs such as eculizumab (Soliris); CPT codes are five-character codes maintained by the AMA. On a Part B claim J1299 reports the drug itself in 2 mg units, and the administration is billed on its own line.

What is the Medicare reimbursement for J1299 in October 2026?

The ASP-based payment limit is $43.763 per 2 MG, with 20% beneficiary coinsurance. The July 2026 limit was $44.198. Commercial payers use their own fee schedules.

How many units of J1299 can be billed per day?

The practitioner Medically Unlikely Edit is 600 units per date of service with adjudication indicator 3 (Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J1299?

The October 2026 ASP crosswalk lists 1 NDC from 1 labeler: Soliris (Alexion Pharmaceuticals, Inc.). For example NDC 25682-0001-01 (package size 30) equals 150 billing units of J1299.

Does J1299 have NCCI bundling edits?

No active practitioner PTP pairs list J1299 as a column-1 or column-2 code in the v323r0 release.

J1299 vs Q5151: what is the difference?

Both are HCPCS Level II codes whose descriptor names eculizumab. What sets Q5151 apart: biosimilar eculizumab-aagh (Epysqli) from Nupathe Inc. J1299 is billed per 2 mg, limit $43.763, MUE 600; Q5151 is billed per 2 mg, limit $31.547, MUE 600. Report the code whose descriptor matches the product and setting in the record.

J1299 vs Q5152: what is the difference?

Both are HCPCS Level II codes whose descriptor names eculizumab. What sets Q5152 apart: biosimilar eculizumab-aeeb (Bkemv) from Amgen Inc. J1299 is billed per 2 mg, limit $43.763, MUE 600; Q5152 is billed per 2 mg, limit $40.412, MUE 600. Report the code whose descriptor matches the product and setting in the record.

Which Medicare coverage articles mention J1299?

1 current Billing and Coding Article in the Medicare Coverage Database lists J1299, covering 5 states: A54548 (Billing and Coding: Eculizumab, and Biosimilars: EPYSQLI®-eculizumab-aagh, and BKEMV™-eculizumab-aeeb).

What diagnosis codes support J1299?

One Medicare billing and coding article lists 18 covered ICD-10-CM codes for J1299, for example D59.31 (Infection-associated hemolytic-uremic syndrome); D59.32 (Hereditary hemolytic-uremic syndrome); D59.39 (Other hemolytic-uremic syndrome); D59.5 (Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]); G36.0 (Neuromyelitis optica [Devic]). Each contractor's list applies only in its own jurisdiction, so the claim must carry a code from the article of the contractor that processes it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B, ASC Addendum BB and the Medicare Coverage Database. Payment limits and rates are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.